Search

Elanco Animal Health Inc

Închisă

SectorSănătate

24.48 3.73

Rezumat

Modificarea prețului

24h

Curent

Minim

23.35

Maxim

23.82

Indicatori cheie

By Trading Economics

Venit

-3M

54M

Vânzări

-3M

1.4B

P/E

Medie Sector

372.714

57.371

EPS

0.34

Marjă de profit

3.947

Angajați

9,400

EBITDA

-42M

274M

Recomandări

By TipRanks

Recomandări

Puternic Cumpărare

Prognoză pe 12 luni

+32.7% upside

Dividende

By Acuity

Următoarele câștiguri

4 nov. 2026

Statistici piață

By TradingEconomics

Capitalizare de piață

-1.1B

12B

Deschiderea anterioară

20.75

Închiderea anterioară

24.48

Sentimentul știrilor

By Acuity

60%

40%

289 / 340 Clasament în Healthcare

Elanco Animal Health Inc Grafic

Performanțele din trecut nu reprezintă un indicator fiabil al rezultatelor viitoare.

Știri relevante

17 aug. 2026, 19:26 UTC

Elanco Animal Health shares are lower today, trading flat since Friday's close. The stock remains below its 20-day moving average with no specific news driving the decline.

14 aug. 2026, 23:36 UTC

Elanco Animal Health shares declined in after-market trading, remaining below the 20-day moving average amid concerns over a surprising drop in U.S. retail sales.

13 aug. 2026, 20:06 UTC

Elanco Animal Health Inc shares are higher today amid a broader market uptrend. The stock remains below its 20-day moving average.

12 aug. 2026, 19:51 UTC

Elanco Animal Health shares are declining today, despite high trading volume. No specific news was identified to explain the downward movement.

11 aug. 2026, 19:36 UTC

News

Elanco Animal Health receives FDA Emergency Use Authorization for CLiK Extra wound spray to combat New World screwworm infestations, boosting shares during Tuesday's session.

10 aug. 2026, 23:06 UTC

Elanco Animal Health shares are higher in after-market trading, following notable volatility during the session. The stock remains below its 20-day moving average.

7 aug. 2026, 23:36 UTC

Elanco Animal Health shares are higher in after-market trading, following a session spike despite no specific company news identified.

6 aug. 2026, 23:36 UTC

Elanco Animal Health Inc shares are higher in after-market hours. No specific news was identified to explain this movement, which shows routine trading.

5 aug. 2026, 19:52 UTC

News

Elanco Animal Health reported second-quarter revenue of $1.368 billion and raised its full-year adjusted EPS guidance to between $1.10 and $1.16. Shares are higher.

4 aug. 2026, 23:01 UTC

Elanco Animal Health Inc shares are higher in after-market hours, recovering from three days of declines amid broader market optimism and easing oil prices.

3 aug. 2026, 20:02 UTC

Elanco Animal Health is trading lower amid a broader market decline, reflecting negative sentiment in the pharmaceuticals sector. No specific news was identified.

31 iul. 2026, 23:01 UTC

Elanco Animal Health Inc shares are lower in after-market hours, trading near the lower end of their one-month range with no specific news identified.

30 iul. 2026, 16:11 UTC

Elanco Animal Health is lower today, influenced by declines in the Pharmaceuticals sub-sector. The stock remains above its 20-day moving average.

29 iul. 2026, 18:14 UTC

Elanco Animal Health shares are higher today, breaking a pattern of recent daily closes. No specific news was identified to explain the movement.

28 iul. 2026, 18:26 UTC

Correlated Moves
News

Bank of America maintains its buy rating on Elanco Animal Health, citing a favorable catalyst profile ahead of second-quarter earnings. Shares are higher today.

27 iul. 2026, 18:36 UTC

Elanco Animal Health is trading higher, reflecting positive market conditions, though no specific news was identified to explain the price movement.

24 iul. 2026, 19:26 UTC

Elanco Animal Health shares are higher, reflecting broader market dynamics amid a pullback in crude oil prices and easing energy-related pressures.

23 iul. 2026, 10:16 UTC

Elanco Animal Health is trading roughly flat in pre-market hours, despite broader market declines influenced by earnings reports and rising oil prices.

22 iul. 2026, 19:25 UTC

News

Elanco Animal Health trades higher as Morgan Stanley raises price target to $26. New data shows Credelio Quattro effectively kills ticks faster than competitors.

21 iul. 2026, 19:26 UTC

Elanco Animal Health shares are higher, continuing a positive trend since Monday. Broader market optimism follows strong earnings from General Motors and Novartis.

20 iul. 2026, 19:46 UTC

Elanco Animal Health Inc. shares are lower today, continuing a decline since Friday's close, despite an earlier peak in the session.

Comparație

Modificare preț

Elanco Animal Health Inc Așteptări

Obiectiv de preț

By TipRanks

32.7% sus

Prognoză pe 12 luni

Medie 31.33 USD  32.7%

Maxim 34 USD

Minim 26 USD

În baza a 12 analiști de pe Wall Street care oferă obiective de preț pe 12 luni pentruElanco Animal Health Inc - Dist în ultimele 3 luni.

Consens privind evaluarea

By TipRanks

Puternic Cumpărare

12 ratings

11

Cumpărare

1

Păstrare

0

Vânzare

Sentiment

By Acuity

289 / 340 Clasament în Sănătate

Sentimentul știrilor

Evidențe de scădere

Volatilitate

Sub medie

Volumul știrilor (RCV)

Sub medie

Date financiare

Cheltuieli de vânzare și administrare

Cheltuieli de exploatare

Profit pre-impozitare

Vânzări

Costul vânzărilor

Profit brut din vânzări

Cheltuieli cu dobânzile pe datorie

EBITDA

Profit operațional

$

Despre Elanco Animal Health Inc

Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals. It offers pet health disease prevention products, such as parasiticide and vaccine products that protect pets from worms, fleas, and ticks under the Seresto, Advantage, Advantix, and Advocate brands; pet health therapeutics for pain, osteoarthritis, ear infections, cardiovascular, and dermatology indications in canines and felines under the Galliprant and Claro brands; vaccines, antibiotics, parasiticides, and other products for use in poultry and aquaculture production, as well as nutritional health products, including enzymes, probiotics, and prebiotics; and a range of vaccines, antibiotics, implants, parasiticides, and other products used in ruminant and swine production under the Rumensin and Baytril brands. The company sells its products to third-party distributors; veterinarians; and farm animal producers, including beef and dairy farmers, as well as pork, poultry, and aquaculture operations. Elanco Animal Health Incorporated was founded in 1954 and is headquartered in Greenfield, Indiana.
help-icon Live chat